
Loading, please wait...

Loading, please wait...

Researchers at NITK Surathkal recently developed an advanced bioactive and antimicrobial implant coating to improve orthopaedic surgeries. Consequently, this patented technology marks a significant milestone in Indian biomedical engineering. Specifically, the team engineered this novel solution to address the rising challenges of implant-associated infections. These infections often lead to implant loosening and suboptimal long-term performance in conventional joint replacements. Therefore, this innovation represents a major step forward for millions of patients globally.
The research team applied the composite coating directly using an optimized high-velocity oxy-fuel (HVOF) thermal spray process. Subsequently, this method delivers localized antimicrobial protection and simultaneously improves the implant's mechanical durability. Furthermore, this technology enhances wear resistance, coating adhesion, and osseointegration. As a result, the bone integrates more effectively with the implant, which builds a much stronger biological bond. Simultaneously, the antimicrobial functionality actively combats bacterial growth at the surgical site. Ultimately, this combined action substantially reduces the risk of post-surgical infections and subsequent joint failures.
During preclinical studies, the coating demonstrated highly promising performance compared to conventional implants on the market. Consequently, this technology has the potential to significantly reduce the need for painful revision surgeries. Additionally, Dr. Sudhakar C. Jambagi and his doctoral student, Dr. Deep Shankar, patented this breakthrough innovation. Subsequently, Dr. Shankar founded a deep-tech startup to commercialize the patented technology. Currently, the team is actively working toward clinical translation to bring this solution to patients. Moreover, this indigenous development strongly aligns with India's vision for advanced, self-reliant healthcare solutions.
Q1: How does the new antimicrobial implant coating prevent joint infections?
The coating combats bacterial colonization directly at the surgical site while simultaneously promoting faster, stronger bone integration.
Q2: Why is the high-velocity oxy-fuel (HVOF) thermal spray process important?
This specific process allows researchers to apply the durable composite coating uniformly and securely onto the implant surface.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers at NITK Surathkal have patented an advanced antimicrobial and bioactive coating to prevent post-surgical joint replacement infections....
4 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today